Medicana
Cannabis is a plant widely studied and used to treat various health conditions, including chronic pain, anxiety, epilepsy and neurological diseases. In Brazil, the sale of medicinal Cannabis is regulated by ANVISA and requires a specific process for acquisition. Faced with this need, UAI HEMP needed a complete system that would guarantee easy and humanized access to cannabis-based medicines in Brazil. GAFIT has developed a responsive system that not only manages and improves users' access to medicines, but also meets all import requirements, with an effective design that promotes user engagement in a simple and direct way, ensuring a positive and well-functioning experience. successful in obtaining medicines and in the treatment process.
PROJECT DETAILS
- CATEGORY Website